Minerva Neurosciences NERV
NASDAQ NERV
$2.46 -0.17 (-6.46%)
As of: Nov 10, 2026 · 3:10 PM EST

Minerva Neurosciences (NERV) EV to EBITDA (2020 - 2023)

Updated

Minerva Neurosciences' (NERV) EV to EBITDA was -3.08 for Q1 2023.

Analysis

Minerva Neurosciences (NERV) EV to EBITDA (2020 - 2023) Analysis & Trends

Over the twelve months ended Mar 31, 2023, Minerva Neurosciences' EV to EBITDA came in at -17.23; for FY2020, it was 36.88.

  • The Q1 2023 figure ranks as the highest quarterly EV to EBITDA since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Minerva Neurosciences 121.62 Mn -126.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -3.08
Dec 31, 2020 36.87
API Access

Minerva Neurosciences EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=NERV&period=max&api_key=YOUR_API_KEY